129.900

+0.700 (+0.54%)

Range 129.070 - 130.480   (1.09%)
Open 129.660
Previous Close 129.200
Buy Price 139.990
Buy Volume -
Sell Price 140.000
Sell Volume -
Volume 6,720,265
Value -
Remark
Measurement Type Value
EPS (USD) 5.796
Trailing EPS (USD) 6.529
NAV (USD) -
Cash In Hand (USD) -
Dividend 3.571
Dividend Yield (%) 2.764
PE 22.291
Trailing PE 19.789
Price / NAV -
Price / Cash In Hand -
Issued & Paid-up Shares 2,639,170,000
Treasury Shares 477,778,000
Market Cap (M) 340,980.764
Par Value (USD) n.a.
Beta - 75 Days 0.351
R-Squared - 75 Days(%) 7.11
Beta - 500 Days 0.631
R-Squared - 500 Days(%) 19.21
ISIN Code -
Under CPF Investment Scheme (CPFIS) No
Index Components
Delayed prices. Updated at 24 Oct 2019 04:00.
Data powered by

Upcoming Events

Earnings

Release Date: 28 Jan 2020

Dividend

Ex-Date: 25 Nov 2019
Record Date: 26 Nov 2019
Payable Date: 10 Dec 2019
Johnson & Johnson Declares Quarterly Dividend of $0.95 Per Share
Data powered by SGX. View More
View All Events

About JOHNSON & JOHNSON

Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a broad range of products in the health care field. The business of Johnson & Johnson is conducted by more than 275 operating companies located in 60 countries, including the United States, which sell products in virtually all countries throughout the world. In March 2013, Johnson & Johnson's Cordis Corporation announced the acquisition of Flexible Stenting Solutions, Inc. In June 2013, Johnson & Johnson announced the opening of the Johnson & Johnson Innovation center in Boston. In July 2014, Johnson & Johnson completed the divestiture of Ortho-Clinical Diagnostics business to Carlyle Group.


Loading Chart...


BUY
SELL
Stock
JOHNSON & JOHNSON(JNJ)
Target Price
Add Stop Loss
Time Frames